Bill > LD2019

This bill modifies the licensure process for prescription drug manufacturers and wholesalers in Maine by allowing applicants to apply for a license before obtaining their federal registration numbers from the Drug Enforcement Administration (DEA) and Food and Drug Administration (FDA). Under the new provisions, applicants must still submit their license forms with as much information as possible, including their name, address, contact details, and ownership status. If the applicant has not yet received their federal registration numbers at the time of application, they will be required to file those numbers with the Maine Board of Pharmacy once they are obtained. The bill also establishes that the Board of Pharmacy may deny, refuse to renew, or impose disciplinary sanctions on a manufacturer or wholesaler's license if they fail to submit their federal registration numbers after obtaining them. This change is designed to streamline the licensure process while ensuring that all necessary regulatory information is ultimately provided to the state pharmacy board. The bill is being enacted as emergency legislation to address potential barriers to business operations for pharmaceutical companies in Maine.

Health and Social Services

https://legislature.maine.gov/legis/bills/display_ps.asp?LD=2019&snum=132